| Ann M Metzger, MD | |
|
2996 7th Ave, Suite B, Marion, IA 52302-3713 | |
| (319) 377-4844 | |
| (319) 377-0852 |
| Full Name | Ann M Metzger |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 2996 7th Ave, Marion, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437137668 | NPI | - | NPPES |
| 5097204 | Medicaid | IA | |
| 4097204 | Medicaid | IA | |
| 1437137668 | Medicaid | IA | |
| 6097204 | Medicaid | IA | |
| 080102643 | Other | IA | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 30018 (Iowa) | Primary |
| Entity Name | The Finley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073560462 PECOS PAC ID: 5092622944 Enrollment ID: O20040122001079 |
News Archive
SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint today announced that iFuse initial post-market clinical experience will be presented at upcoming 2010 minimally invasive spine surgery meetings.
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
An analysis of medical-surgical sales through distribution conducted by GHX has found that among the top 100 U.S. medical-surgical manufacturers by dollar spend, those that use GHX Market Intelligence data grew medical-surgical revenue through distribution by an average of 6.42 percent in 2009, while non-users grew similarly classified revenue by an average of only 3.88 percent. Furthermore, GHX's analysis also found that those manufacturers employing more granular-level market data from GHX increased revenue at a faster rate than those using higher-level data.
Barth Syndrome (BTHS) is a rare and serious genetic disorder that primarily affects males and is passed from mother to son; women who are carriers do not show symptoms of the disorder. Fifty percent of children born to a mother who is a carrier will inherit the defective gene, and all daughters born to an affected man will be carriers. BTHS is caused by a mutation in the tafazzin gene that results in decreased production of cardiolipin, an essential lipid for energy metabolism.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ann M Metzger, MD 2996 7th Ave, Suite B, Marion, IA 52302-3713 Ph: (319) 377-4844 | Ann M Metzger, MD 2996 7th Ave, Suite B, Marion, IA 52302-3713 Ph: (319) 377-4844 |
News Archive
SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint today announced that iFuse initial post-market clinical experience will be presented at upcoming 2010 minimally invasive spine surgery meetings.
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
An analysis of medical-surgical sales through distribution conducted by GHX has found that among the top 100 U.S. medical-surgical manufacturers by dollar spend, those that use GHX Market Intelligence data grew medical-surgical revenue through distribution by an average of 6.42 percent in 2009, while non-users grew similarly classified revenue by an average of only 3.88 percent. Furthermore, GHX's analysis also found that those manufacturers employing more granular-level market data from GHX increased revenue at a faster rate than those using higher-level data.
Barth Syndrome (BTHS) is a rare and serious genetic disorder that primarily affects males and is passed from mother to son; women who are carriers do not show symptoms of the disorder. Fifty percent of children born to a mother who is a carrier will inherit the defective gene, and all daughters born to an affected man will be carriers. BTHS is caused by a mutation in the tafazzin gene that results in decreased production of cardiolipin, an essential lipid for energy metabolism.
› Verified 1 days ago
James E Mccabe, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2996 7th Ave, Ste B, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Thomas J Richmann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 35th St, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Julie Hoffmann, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-373-3022 Fax: 319-373-0208 | |
Deepti Smitha Kurra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2996 7th Ave Ste B, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Arleen Zahn-houser, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-373-8708 Fax: 319-373-8774 | |
Dr. Jaclyn M Price, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-377-3174 Fax: 319-377-9368 | |
Ms. Larae Gail Stemmerman, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 905 29th Ave Ste 120, Marion, IA 52302 Phone: 319-826-6374 Fax: 319-826-6377 |